Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.24 USD | +1.34% | +14.90% | +9.21% |
02/05 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
02/05 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.21% | 1.73B | |
+73.53% | 12.41B | |
-16.51% | 7.87B | |
+7.84% | 6.37B | |
+3.66% | 5.81B | |
+13.79% | 5.36B | |
+40.99% | 4.92B | |
-19.73% | 4.02B | |
-34.47% | 2.43B | |
+0.74% | 2.02B |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Transcript : NovoCure Limited Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 07